FLAGSTAFF, Ariz.--(BUSINESS WIRE)--W. L. Gore & Associates (Gore) has announced that the GORE® VIABAHN® VBX Balloon Expandable Endoprosthesis (VBX Stent Graft) has received U.S. Food & Drug ...
(MENAFN- PR Newswire) With improvements to the stent graft delivery system enabling a 1 Fr profile reduction on the majority of sizes, the device now offers the most 6 Fr compatible configurations ...
(MENAFN- PR Newswire) The EMBRACE Registry aims to evaluate safety and performance of the GORE® VIABAHN® VBX Balloon Expandable Endoprosthesis when used as a bridging stent with branched and ...
The GORE ® VIABAHN ® VBX Balloon Expandable Endoprosthesis indication expansion brings the first bridging stent device with dual indication for both fenestrated and branched endovascular repair*.
Gore won FDA approval for its VIABAHN VBX endoprosthesis to be used in the iliac arteries, making it the only balloon expandable stent graft having such an indication. It can be used on new or ...
W. L. Gore & Associates, Inc. (Gore) has announced that the first implants occurred in Europe to restore blood flow to peripheral arteries using the GORE ® VIABAHN ® VBX Balloon Expandable ...
FLAGSTAFF, Ariz.--(BUSINESS WIRE)--W. L. Gore & Associates (Gore) today announced the availability of a new 7.5 centimeter length of the GORE® VIABAHN® Endoprosthesis with Heparin Bioactive Surface.
The GORE ® VIABAHN ® VBX Balloon Expandable Endoprosthesis indication expansion brings the first bridging stent device with dual indication for both fenestrated and branched endovascular repair*.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results